A generic mechanism in Neisseria meningitidis for enhanced resistance against bactericidal antibodies. - Wikidata - awgldk - TriplyDB

A generic mechanism in Neisseria meningitidis for enhanced resistance against bactericidal antibodies.

A generic mechanism in Neisseria meningitidis for enhanced resistance against bactericidal antibodies.

http://www.wikidata.org/entity/Q36699790

about

How the Knowledge of Interactions between Meningococcus and the Human Immune System Has Been Used to Prepare Effective Neisseria meningitidis Vaccines The meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factor H and enhances meningococcal resistance to complement Transcriptional profiling of serogroup B Neisseria meningitidis growing in human blood: an approach to vaccine antigen discovery Infections of People with Complement Deficiencies and Patients Who Have Undergone Splenectomy Serogroup-specific interaction of Neisseria meningitidis capsular polysaccharide with host cell microtubules and effects on tubulin polymerization ISMapper: identifying transposase insertion sites in bacterial genomes from short read sequence data The influence of IS1301 in the capsule biosynthesis locus on meningococcal carriage and disease.Emergence of a new Neisseria meningitidis clonal complex 11 lineage 11.2 clade as an effective urogenital pathogen Epidemiological profile of meningococcal disease in the United States Cellular and molecular biology of Neisseria meningitidis colonization and invasive disease sodC-based real-time PCR for detection of Neisseria meningitidis NafA negatively controls Neisseria meningitidis piliation.Inhibition of the classical pathway of complement by meningococcal capsular polysaccharides Genetic study of capsular switching between Neisseria meningitidis sequence type 7 serogroup A and C strains Meningococcal disease and the complement system.Cefditoren and ceftriaxone enhance complement-mediated immunity in the presence of specific antibodies against antibiotic-resistant pneumococcal strains Meningococcal group W-135 and Y capsular polysaccharides paradoxically enhance activation of the alternative pathway of complement.Neisseria meningitidis: biology, microbiology, and epidemiology.α-2,3-sialyltransferase expression level impacts the kinetics of lipooligosaccharide sialylation, complement resistance, and the ability of Neisseria gonorrhoeae to colonize the murine genital tract Resistance of Neisseria meningitidis to human serum depends on T and B cell stimulating protein B.Extensive Capsule Locus Variation and Large-Scale Genomic Recombination within the Klebsiella pneumoniae Clonal Group 258.The relative roles of factor H binding protein, neisserial surface protein A, and lipooligosaccharide sialylation in regulation of the alternative pathway of complement on meningococci Identification of Klebsiella capsule synthesis loci from whole genome data Mechanisms in Neisseria meningitidis for resistance against complement-mediated killing.The role of microbial polysaccharides in host-pathogen interaction Meningococcal disease: shifting epidemiology and genetic mechanisms that may contribute to serogroup C virulence.Regulation of capsule in Neisseria meningitidis.Bacterial Surfaces: Front Lines in Host-Pathogen Interaction.Genetic Analysis of Neisseria meningitidis Sequence Type 7 Serogroup X Originating from Serogroup A.Characterization of an antibody depletion assay for analysis of bactericidal antibody specificity.Characterization of fHbp, nhba (gna2132), nadA, porA, sequence type (ST), and genomic presence of IS1301 in group B meningococcal ST269 clonal complex isolates from England and Wales Analysis of the SDS-PAGE patterns of outer membrane proteins from Escherichia coli strains that have lost the ability to form K1 antigen and varied in the susceptibility to normal human serum.Characterization of Neisseria meningitidis isolates that do not express the virulence factor and vaccine antigen factor H binding protein.Temperature triggers immune evasion by Neisseria meningitidis.Progress toward the global control of Neisseria meningitidis: 21st century vaccines, current guidelines, and challenges for future vaccine development.Spontaneous point mutations in the capsule synthesis locus leading to structural and functional changes of the capsule in serogroup A meningococcal populations

P2860

Q26782340-CD498F0C-27D8-481E-8290-59538DB2D8BE Q28474974-A66C6173-CFD3-4AC7-9F1D-2A0332DE5342 Q28728122-CE33F8BF-2BDD-4383-9405-64CE4B30A657 Q28972389-13613C3A-96B6-4927-8736-C32C10EE6770 Q30570573-61088BD4-DC29-4A9B-97D7-8D93F0B30247 Q30991359-5AF152C8-746F-4DBA-90E9-F9EEB7DF6A0C Q33535924-35F1B233-27D4-419D-8497-60800CF02554 Q33594778-965CF983-D0FF-4312-BC8E-07B804D46752 Q33648635-BC8F1FDA-1B53-4587-BF28-7FE67DF96118 Q33696949-EC0B69C9-6895-4304-8773-2D3F9CD8492E Q33900857-619EB93E-1A2A-416A-A4D8-806097AF72BB Q33958083-082C9A03-E61F-472A-BAFD-C823FEA20C6B Q33992223-BE25A850-ED73-4CDD-BED8-533C98F4586B Q34119434-3E0F0BD4-244C-467B-9AF8-36F9793F3929 Q34376170-40D579ED-6039-4B0F-B867-CE0988854A20 Q34408016-10ED9C06-5BD9-4F9F-AC62-3BC98F0393BE Q34624357-5F7791EC-A5C4-4ABF-A94E-90CF5977778D Q34632986-369AAB95-0E08-4307-8FD1-AF495359654A Q35072338-47FDC9E1-B9B0-4DF7-81EB-5A074459DA79 Q35187613-38578B7B-55DB-4804-8198-01ADA624125E Q35599331-A112EC15-03AF-4DE6-A294-A4CFD439A0B2 Q35936064-73BFCBCC-8680-4087-99F4-6CB3E66ECF2B Q36324802-CA74F443-A49A-4AE0-8C68-190C52E91B0F Q37456608-023C35A8-6CAD-4292-9D2C-2BA6FF5600AB Q37800370-EFCCDCF5-464A-4349-A3A2-0628BFEE6FFF Q37878375-9A4CD0D3-D538-4A5C-82AE-534344B06609 Q38531723-37A45603-07A0-4419-A347-5BA7755E1334 Q38837720-B8A365FA-5325-4AAC-AF43-3B6F74AB7D04 Q40287241-33C399F5-FA1B-4B24-8AC0-2033AF464240 Q41774048-053E9A5D-D592-4921-8387-ECCF196D872E Q41845489-245C5966-72D1-4A66-A596-8EFD466B52D6 Q41867568-33D6DDD7-946E-4AE3-954B-0D04DB37D415 Q41922489-190569EB-9777-4DD0-8032-863CDE768E74 Q42267002-42ED1AE6-D1EE-4518-AF31-121B544D0F5D Q54255446-E4E54257-32C9-48C6-B760-AC00C574A8BA Q58806131-A3950C0D-E5B3-43F2-A36E-9AE20858F177

P2860

A generic mechanism in Neisseria meningitidis for enhanced resistance against bactericidal antibodies.

http://www.wikidata.org/entity/Q36699790

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

A generic mechanism in Neisser ...... ainst bactericidal antibodies.

@ast

A generic mechanism in Neisser ...... ainst bactericidal antibodies.

@en

type

label

A generic mechanism in Neisser ...... ainst bactericidal antibodies.

@ast

A generic mechanism in Neisser ...... ainst bactericidal antibodies.

@en

prefLabel

A generic mechanism in Neisser ...... ainst bactericidal antibodies.

@ast

A generic mechanism in Neisser ...... ainst bactericidal antibodies.

@en

P1433

Q36699790-67CA6FA1-7296-423E-A258-059D16786B7C

P1476

Q36699790-800DC891-B49F-41B6-A15B-7BA620B7FC3E

P2093

Q36699790-10856DCB-629D-4604-8C7C-AACE7BE8CDAB

Q36699790-1091A73F-1294-4097-9BC0-6FD91DB372AF

Q36699790-1C6DF0AD-A39E-489A-B778-DF97CF2DC31E

Q36699790-880BC93A-936A-48F8-BC20-F856F6B63F4A

Q36699790-B1D0903D-87F2-431D-AD43-6CB1653FDFF5

Q36699790-B27B4A6D-6A67-4A03-BA24-41E23FF3E730

Q36699790-B7459C35-4CC9-4CC0-9E95-C7375E0D0885

Q36699790-C63FB660-A6E7-4317-9B59-C652B3A7C122

Q36699790-C71F5BC4-003E-49D4-8262-58A63206CA44

Q36699790-D6C98988-0FC9-45C0-A639-D015670DDF89

P2860

Q36699790-02CF2A1D-5057-42F5-9F25-400B8A711045

Q36699790-02DCA213-3813-4733-A6E2-BC237EF5BF85

Q36699790-093AE4A7-5BE8-4D74-A902-1A0AA0B3E716

Q36699790-0E45472D-1D75-43D2-BAE1-669A737739D5

Q36699790-10A577CF-0382-4FE8-8775-82E0099D8775

Q36699790-12BF60EB-D9BD-4AE7-9805-203DC1E827C4

Q36699790-1732E2CB-1DB2-457D-9248-B451D1C460AE

Q36699790-1CE0D96A-D031-416F-A762-F7296DA9DE6C

Q36699790-1DAB7EDB-41AD-4DE1-9E2E-501FCAB0A5DE

Q36699790-20134C35-1953-4DBE-BB9A-E332A465C75F

P304

Q36699790-D52B276E-68A1-479E-8BBA-F41F96259B58

P31

Q36699790-23B8FC5D-AEC4-4D68-AD1C-128212112180

P356

Q36699790-91896FF0-0B8C-4BA1-958E-44348500C86D

P407

Q36699790-490C9612-49E0-4757-A884-A547C6D62C75

P433

Q36699790-70BFBF1D-AD26-4A43-8475-E7FFF4975529

P478

Q36699790-26C0CE67-A1CE-4A62-8CD2-F0D97334F518

P50

Q36699790-C7DDF181-2220-42D3-B0C5-2E40467D4BF6

P577

Q36699790-C4875C7C-07BF-458B-A607-93F21D7D7A2B

P5875

Q36699790-F8B8137C-72A8-4FDD-8CC4-FBFC9B5ACAF4

P698

Q36699790-8E944309-3D57-418E-875A-E9977CC20808

P921

Q36699790-57A29E2F-1D7D-42F1-A262-F4EF9533A4FB

Q36699790-AB4B2E53-C2C0-414E-BEF3-3E13766AFE73

P932

Q36699790-D087EBF1-A5D8-446A-899E-549B3A431768

P356

P1433

Journal of Experimental Medicine

P1476

A generic mechanism in Neisser ...... ainst bactericidal antibodies.

@en

P2093

Andy Yarwood

http://www.w3.org/2001/XMLSchema#string

Angel Chan

http://www.w3.org/2001/XMLSchema#string

Barbara Mulloy

http://www.w3.org/2001/XMLSchema#string

Bridget Gollan

http://www.w3.org/2001/XMLSchema#string

Christoph M Tang

http://www.w3.org/2001/XMLSchema#string

Hannah Chan

http://www.w3.org/2001/XMLSchema#string

Ian Feavers

http://www.w3.org/2001/XMLSchema#string

Julio A Vazquez

http://www.w3.org/2001/XMLSchema#string

Maria Jose Uria

http://www.w3.org/2001/XMLSchema#string

Qian Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Lateral gene transfer and the nature of bacterial innovation

Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms

Complement. First of two parts

Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction

Infectious diseases associated with complement deficiencies.

Cationized ferritin as a stain for electron microscopic observation of bacterial ultrastructure.

Mechanisms of neisserial serum resistance.

Age-dependent Neisseria meningitidis serogroup C class-specific antibody concentrations and bactericidal titers in sera from young children from Montana immunized with a licensed polysaccharide vaccine.

Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story.

Full 1H NMR assignment and detailed O-acetylation patterns of capsular polysaccharides from Neisseria meningitidis used in vaccine production.

P304

1423-1434

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20072577

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

205

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5346581

http://www.w3.org/2001/XMLSchema#string

P698

18504306

http://www.w3.org/2001/XMLSchema#string

P921

Neisseria meningitidis

P932

2413038

http://www.w3.org/2001/XMLSchema#string